A 8467

  • New York Assembly Bill
  • 2023 Regular Session
  • Introduced in Assembly
  • Passed Assembly Feb 26, 2024
  • Passed Senate Mar 11, 2024
  • Signed by Governor Dec 17, 2024

Relates to the dispensing of drug adulterant testing supplies by health care professionals or pharmacists

Abstract

Includes xylazine and other substances in the definition of drug adulterant testing supplies for the purposes of the dispensing of such supplies by health care professionals or pharmacists to any person.

Bill Sponsors (2)

Votes


Actions


Dec 17, 2024

Assembly

SIGNED CHAP.598

Dec 12, 2024

Assembly

DELIVERED TO GOVERNOR

Mar 11, 2024

Senate

SUBSTITUTED FOR S7833A

Senate

RETURNED TO ASSEMBLY

Senate

PASSED SENATE

Senate

3RD READING CAL.412

Feb 26, 2024

Assembly

DELIVERED TO SENATE

Assembly

PASSED ASSEMBLY

Senate

REFERRED TO ALCOHOLISM AND SUBSTANCE USE DISORDERS

Feb 15, 2024

Assembly

ADVANCED TO THIRD READING CAL.314

Feb 13, 2024

Assembly

REPORTED

Feb 08, 2024

Assembly

PRINT NUMBER 8467A

Assembly

AMEND AND RECOMMIT TO HEALTH

Jan 03, 2024

Assembly

REFERRED TO HEALTH

Dec 29, 2023

Assembly

REFERRED TO HEALTH

Bill Text

Bill Text Versions Format
A8467 PDF HTML
A8467A PDF

Related Documents

Document Format
No related documents.

Sources

Data on Open States is updated periodically throughout the day from the official website of the New York Legislature.

If you notice any inconsistencies with these official sources, feel free to file an issue.